{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T13:08:02Z","timestamp":1765285682565,"version":"3.46.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["2018\/02\/X\/NZ5\/00403"],"award-info":[{"award-number":["2018\/02\/X\/NZ5\/00403"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27414-x","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:45:14Z","timestamp":1765280714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diversified, endothelial cell-dependent cancer cell response to hypertensive serum modified by antihypertensive drugs"],"prefix":"10.1038","volume":"15","author":[{"given":"Pawe\u0142","family":"Uruski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Miku\u0142a-Pietrasik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Tykarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Ksi\u0105\u017cek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"1","key":"27414_CR1","doi-asserted-by":"publisher","first-page":"8565","DOI":"10.1038\/s41598-019-45014-4","volume":"9","author":"A Seretis","year":"2019","unstructured":"Seretis, A. et al. Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies. Sci. Rep. 9(1), 8565 (2019).","journal-title":"Sci. Rep."},{"issue":"5","key":"27414_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nrurol.2010.46","volume":"7","author":"WH Chow","year":"2010","unstructured":"Chow, W. H., Dong, L. M. & Devesa, S. S. Epidemiology and risk factors for kidney cancer. Nat. Rev. Urol. 7(5), 245\u2013257 (2010).","journal-title":"Nat. Rev. Urol."},{"key":"27414_CR3","doi-asserted-by":"crossref","unstructured":"Connaughton, M. & Dabagh, M., Association of hypertension and organ-specific cancer: a meta-analysis. Healthcare (Basel). 10(6), (2022).","DOI":"10.3390\/healthcare10061074"},{"issue":"1","key":"27414_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00345-016-1850-2","volume":"35","author":"NJ Kocher","year":"2017","unstructured":"Kocher, N. J. et al. Hypertension is the primary component of metabolic syndrome associated with pathologic features of kidney cancer. World J. Urol. 35(1), 67\u201372 (2017).","journal-title":"World J. Urol."},{"issue":"1","key":"27414_CR5","doi-asserted-by":"publisher","first-page":"10291","DOI":"10.1038\/s41598-020-67329-3","volume":"10","author":"JH Seo","year":"2020","unstructured":"Seo, J. H. et al. Hypertension is associated with oral, laryngeal, and esophageal cancer: a nationwide population-based study. Sci. Rep. 10(1), 10291 (2020).","journal-title":"Sci. Rep."},{"key":"27414_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.610157","volume":"11","author":"R Yang","year":"2020","unstructured":"Yang, R. et al. The relationship between antihypertensive drugs and cancer: anxiety to be resolved in urgent. Front. Pharmacol. 11, 610157 (2020).","journal-title":"Front. Pharmacol."},{"issue":"7","key":"27414_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1470-2045(10)70106-6","volume":"11","author":"I Sipahi","year":"2010","unstructured":"Sipahi, I. et al. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. Lancet Oncol. 11(7), 627\u2013636 (2010).","journal-title":"Lancet Oncol."},{"key":"27414_CR8","unstructured":"Cho, I. J. et al. Antihypertensive drugs and the risk of cancer: a nationwide cohort study. J Clin Med. 10(4), (2021)."},{"issue":"2","key":"27414_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41416-022-02029-5","volume":"128","author":"Z Wu","year":"2023","unstructured":"Wu, Z. et al. Association between angiotensin-converting enzyme inhibitors and the risk of lung cancer: a systematic review and meta-analysis. Br. J. Cancer 128(2), 168\u2013176 (2023).","journal-title":"Br. J. Cancer"},{"issue":"4","key":"27414_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1185\/03007995.2013.772505","volume":"29","author":"M Monami","year":"2013","unstructured":"Monami, M. et al. Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials. Curr.. Med. Res. Opin. 29(4), 369\u2013378 (2013).","journal-title":"Curr.. Med. Res. Opin."},{"issue":"4","key":"27414_CR11","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1097\/HJH.0b013e3282f3ef5e","volume":"26","author":"CI Coleman","year":"2008","unstructured":"Coleman, C. I. et al. Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials. J. Hypertens. 26(4), 622\u2013629 (2008).","journal-title":"J. Hypertens."},{"key":"27414_CR12","doi-asserted-by":"crossref","unstructured":"Sharma, A. E. et al. The impact of beta blockers on survival in cancer patients: a systematic review and meta-analysis. Cancers (Basel). 17(8), (2025).","DOI":"10.3390\/cancers17081357"},{"key":"27414_CR13","doi-asserted-by":"crossref","unstructured":"Yang, H. et al. Association between the overall risk of prostate cancer and use of calcium channel blockers: a systematic review and meta-analysis. Clin. Ther. 42(9), 1715\u20131727 e2 (2020).","DOI":"10.1016\/j.clinthera.2020.06.021"},{"issue":"11","key":"27414_CR14","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3390\/biom14111374","volume":"14","author":"P Uruski","year":"2024","unstructured":"Uruski, P., Miku\u0142a-Pietrasik, J., Tykarski, A. & Ksi\u0105\u017cek, K. Serum from hypertensive patients induces cancer-supporting phenotype of vascular endothelium in vitro. Biomolecules 14(11), 1374 (2024).","journal-title":"Biomolecules"},{"issue":"10","key":"27414_CR15","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams, B. et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology and the European society of hypertension: the task force for the management of arterial hypertension of the European society of cardiology and the European society of hypertension. J. Hypertens. 36(10), 1953\u20132041 (2018).","journal-title":"J. Hypertens."},{"issue":"4","key":"27414_CR16","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2353\/ajpath.2009.080613","volume":"174","author":"K Ksiazek","year":"2009","unstructured":"Ksiazek, K. et al. Senescent peritoneal mesothelial cells promote ovarian cancer cell adhesion: the role of oxidative stress-induced fibronectin. Am. J. Pathol. 174(4), 1230\u20131240 (2009).","journal-title":"Am. J. Pathol."},{"issue":"30","key":"27414_CR17","doi-asserted-by":"publisher","first-page":"29178","DOI":"10.18632\/oncotarget.4932","volume":"6","author":"J Mikula-Pietrasik","year":"2015","unstructured":"Mikula-Pietrasik, J. et al. Colorectal cancer-promoting activity of the senescent peritoneal mesothelium. Oncotarget 6(30), 29178\u201329195 (2015).","journal-title":"Oncotarget"},{"issue":"1","key":"27414_CR18","doi-asserted-by":"publisher","first-page":"12940","DOI":"10.1038\/s41598-018-31037-w","volume":"8","author":"B Kuznar-Kaminska","year":"2018","unstructured":"Kuznar-Kaminska, B. et al. Serum from patients with chronic obstructive pulmonary disease induces senescence-related phenotype in bronchial epithelial cells. Sci. Rep. 8(1), 12940 (2018).","journal-title":"Sci. Rep."},{"key":"27414_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2021.03.004","volume":"156","author":"P Uruski","year":"2021","unstructured":"Uruski, P. et al. Diverse functional responses to high glucose by primary and permanent hybrid endothelial cells in vitro. J. Mol. Cell Cardiol. 156, 1\u20136 (2021).","journal-title":"J. Mol. Cell Cardiol."},{"key":"27414_CR20","doi-asserted-by":"publisher","first-page":"2069290","DOI":"10.1155\/2016\/2069290","volume":"2016","author":"J Mikula-Pietrasik","year":"2016","unstructured":"Mikula-Pietrasik, J. et al. Serum from varicose patients induces senescence-related dysfunction of vascular endothelium generating local and systemic proinflammatory conditions. Oxid. Med. Cell. Longev. 2016, 2069290 (2016).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"27414_CR21","doi-asserted-by":"publisher","first-page":"6167480","DOI":"10.1155\/2017\/6167480","volume":"2017","author":"P Uruski","year":"2017","unstructured":"Uruski, P. et al. Endovenous laser ablation of varicose veins preserves biological properties of vascular endothelium and modulates proinflammatory agent profile more favorably than classic vein stripping. Biomed. Res. Int. 2017, 6167480 (2017).","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"27414_CR22","doi-asserted-by":"publisher","first-page":"7587","DOI":"10.1038\/s41598-019-44123-4","volume":"9","author":"M Pakula","year":"2019","unstructured":"Pakula, M. et al. Senescence-related deterioration of intercellular junctions in the peritoneal mesothelium promotes the transmesothelial invasion of ovarian cancer cells. Sci. Rep. 9(1), 7587 (2019).","journal-title":"Sci. Rep."},{"key":"27414_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.biocel.2017.09.002","volume":"92","author":"J Mikula-Pietrasik","year":"2017","unstructured":"Mikula-Pietrasik, J. et al. Malignant ascites determine the transmesothelial invasion of ovarian cancer cells. Int. J. Biochem. Cell Biol. 92, 6\u201313 (2017).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"27414_CR24","doi-asserted-by":"crossref","unstructured":"Wright, J. M., Musini, V. M. & Gill, R. First-line drugs for hypertension. Cochrane Database Syst. Rev. 4(4), CD001841 (2018).","DOI":"10.1002\/14651858.CD001841.pub3"},{"key":"27414_CR25","doi-asserted-by":"publisher","first-page":"1049640","DOI":"10.3389\/fphar.2022.1049640","volume":"13","author":"NM Abdulkareem","year":"2022","unstructured":"Abdulkareem, N. M. et al. Screening of GPCR drugs for repurposing in breast cancer. Front. Pharmacol. 13, 1049640 (2022).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"27414_CR26","doi-asserted-by":"publisher","first-page":"5919","DOI":"10.1038\/s41467-021-26222-x","volume":"12","author":"M Niu","year":"2021","unstructured":"Niu, M. et al. FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth. Nat. Commun. 12(1), 5919 (2021).","journal-title":"Nat. Commun."},{"key":"27414_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.691998","volume":"12","author":"Q Chen","year":"2021","unstructured":"Chen, Q. et al. Adrenergic blockade by nebivolol to suppress oral squamous cell carcinoma growth via endoplasmic reticulum stress and mitochondria dysfunction. Front. Pharmacol. 12, 691998 (2021).","journal-title":"Front. Pharmacol."},{"issue":"4","key":"27414_CR28","first-page":"825","volume":"22","author":"K Guo","year":"2009","unstructured":"Guo, K. et al. Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol. Oncol. Rep. 22(4), 825\u2013830 (2009).","journal-title":"Oncol. Rep."},{"issue":"18","key":"27414_CR29","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","volume":"70","author":"EK Sloan","year":"2010","unstructured":"Sloan, E. K. et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 70(18), 7042\u20137052 (2010).","journal-title":"Cancer Res."},{"key":"27414_CR30","doi-asserted-by":"crossref","unstructured":"do Vale, G. T. et al. Nebivolol prevents ethanol-induced reactive oxygen species generation and lipoperoxidation in the rat kidney by regulating NADPH oxidase activation and expression. Eur. J. Pharmacol. 799, 33\u201340 (2017).","DOI":"10.1016\/j.ejphar.2017.01.036"},{"key":"27414_CR31","doi-asserted-by":"crossref","unstructured":"Cykowiak, M. et al. Attenuation of pancreatic cancer in vitro and in vivo via modulation of Nrf2 and NF-kappaB signaling pathways by natural compounds. Cells. 10(12), (2021).","DOI":"10.3390\/cells10123556"},{"issue":"13","key":"27414_CR32","first-page":"1503","volume":"102","author":"B Pitt","year":"2000","unstructured":"Pitt, B. et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Prev. Investig. Circ. 102(13), 1503\u20131510 (2000).","journal-title":"Prev. Investig. Circ."},{"issue":"6","key":"27414_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3892\/br.2022.1533","volume":"16","author":"MAY Alqudah","year":"2022","unstructured":"Alqudah, M. A. Y. et al. Amlodipine inhibits proliferation, invasion, and colony formation of breast cancer cells. Biomed. Rep. 16(6), 50 (2022).","journal-title":"Biomed. Rep."},{"key":"27414_CR34","unstructured":"Alqudah, M. A., Alrababah, B. A. & Mhaidat, N. M. Amlodipine inhibits cell proliferation and induces cell cycle arrest in colorectal cancer cells. Jordan J. Pharm. Sci. 10(3), (2017)."},{"key":"27414_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.902305","volume":"13","author":"B Fu","year":"2022","unstructured":"Fu, B. et al. Anticancer effects of amlodipine alone or in combination with gefitinib in non-small cell lung cancer. Front. Pharmacol. 13, 902305 (2022).","journal-title":"Front. Pharmacol."},{"issue":"7","key":"27414_CR36","first-page":"955","volume":"17","author":"SS Patel","year":"2017","unstructured":"Patel, S. S. & Nakka, S. Protective effect of perindopril on tumor progression and angiogenesis in animal model of breast cancer. Anticancer Ag. Med. Chem. 17(7), 955\u2013960 (2017).","journal-title":"Anticancer Ag. Med. Chem."},{"issue":"2","key":"27414_CR37","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1111\/jcmm.14848","volume":"24","author":"J Wen","year":"2020","unstructured":"Wen, J. et al. IL-8 promotes cell migration through regulating EMT by activating the Wnt\/beta-catenin pathway in ovarian cancer. J. Cell. Mol. Med. 24(2), 1588\u20131598 (2020).","journal-title":"J. Cell. Mol. Med."},{"issue":"12","key":"27414_CR38","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/sj.onc.1201307","volume":"15","author":"M Kornmann","year":"1997","unstructured":"Kornmann, M. et al. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Oncogene 15(12), 1417\u20131424 (1997).","journal-title":"Oncogene"},{"issue":"1","key":"27414_CR39","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12885-024-12120-0","volume":"24","author":"T Lin","year":"2024","unstructured":"Lin, T. et al. ART1 knockdown decreases the IL-6-induced proliferation of colorectal cancer cells. BMC Cancer 24(1), 354 (2024).","journal-title":"BMC Cancer"},{"issue":"6","key":"27414_CR40","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/onc.2015.133","volume":"35","author":"MF Pang","year":"2016","unstructured":"Pang, M. F. et al. TGF-beta1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7\/CCL21-mediated chemotaxis. Oncogene 35(6), 748\u2013760 (2016).","journal-title":"Oncogene"},{"key":"27414_CR41","doi-asserted-by":"crossref","unstructured":"Bharadwaj, A. G. et al. Plasmin and plasminogen system in the tumor microenvironment: implications for cancer diagnosis, prognosis, and therapy. Cancers (Basel). 13(8), (2021).","DOI":"10.3390\/cancers13081838"},{"issue":"4","key":"27414_CR42","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1084\/jem.20052124","volume":"203","author":"D Wang","year":"2006","unstructured":"Wang, D. et al. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J. Exp. Med. 203(4), 941\u2013951 (2006).","journal-title":"J. Exp. Med."},{"issue":"Pt 3","key":"27414_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.semcancer.2022.03.011","volume":"86","author":"Y Yang","year":"2022","unstructured":"Yang, Y. & Cao, Y. The impact of VEGF on cancer metastasis and systemic disease. Semin. Cancer Biol. 86(Pt 3), 251\u2013261 (2022).","journal-title":"Semin. Cancer Biol."},{"issue":"10","key":"27414_CR44","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3748\/wjg.14.1575","volume":"14","author":"XH Liu","year":"2008","unstructured":"Liu, X. H. et al. Angiopoietin-1 targeted RNA interference suppresses angiogenesis and tumor growth of esophageal cancer. World J. Gastroenterol. 14(10), 1575\u20131581 (2008).","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"27414_CR45","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1111\/cas.15293","volume":"113","author":"H Hayasaka","year":"2022","unstructured":"Hayasaka, H. et al. CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels. Cancer Sci. 113(4), 1338\u20131351 (2022).","journal-title":"Cancer Sci."},{"issue":"35","key":"27414_CR46","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.2174\/138161210794455003","volume":"16","author":"S Liekens","year":"2010","unstructured":"Liekens, S., Schols, D. & Hatse, S. CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization. Curr. Pharm. Des. 16(35), 3903\u20133920 (2010).","journal-title":"Curr. Pharm. Des."},{"issue":"12","key":"27414_CR47","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1128\/MCB.21.12.4016-4031.2001","volume":"21","author":"Z Lu","year":"2001","unstructured":"Lu, Z. et al. Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol. Cell Biol. 21(12), 4016\u20134031 (2001).","journal-title":"Mol. Cell Biol."},{"issue":"6","key":"27414_CR48","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/ijc.21479","volume":"117","author":"H van Cruijsen","year":"2005","unstructured":"van Cruijsen, H., Giaccone, G. & Hoekman, K. Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies. Int. J. Cancer 117(6), 883\u2013888 (2005).","journal-title":"Int. J. Cancer"},{"issue":"1","key":"27414_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11906-009-0084-8","volume":"12","author":"TM Spruill","year":"2010","unstructured":"Spruill, T. M. Chronic psychosocial stress and hypertension. Curr. Hypertens. Rep. 12(1), 10\u201316 (2010).","journal-title":"Curr. Hypertens. Rep."},{"issue":"8","key":"27414_CR50","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nm1447","volume":"12","author":"PH Thaker","year":"2006","unstructured":"Thaker, P. H. et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 12(8), 939\u2013944 (2006).","journal-title":"Nat. Med."},{"issue":"3","key":"27414_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00001813-200203000-00003","volume":"13","author":"H Yoshiji","year":"2002","unstructured":"Yoshiji, H., Kuriyama, S. & Fukui, H. Perindopril: possible use in cancer therapy. Anticancer Drugs 13(3), 221\u2013228 (2002).","journal-title":"Anticancer Drugs"},{"issue":"11","key":"27414_CR52","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1073\/pnas.1918167117","volume":"117","author":"TY Na","year":"2020","unstructured":"Na, T. Y. et al. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc. Natl. Acad. Sci. U S A 117(11), 5931\u20135937 (2020).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"21","key":"27414_CR53","doi-asserted-by":"publisher","first-page":"30133","DOI":"10.18632\/oncotarget.8780","volume":"7","author":"G Liappas","year":"2016","unstructured":"Liappas, G. et al. Nebivolol, a beta1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis. Oncotarget 7(21), 30133\u201330146 (2016).","journal-title":"Oncotarget"},{"issue":"4","key":"27414_CR54","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3748\/wjg.v30.i4.367","volume":"30","author":"YM Chen","year":"2024","unstructured":"Chen, Y. M. et al. Amlodipine inhibits the proliferation and migration of esophageal carcinoma cells through the induction of endoplasmic reticulum stress. World J. Gastroenterol. 30(4), 367\u2013380 (2024).","journal-title":"World J. Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27414-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27414-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27414-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T13:03:32Z","timestamp":1765285412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27414-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27414"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27414-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43463"}}